Búsqueda de un medicamento huérfano
Otra(s) opcion(es) de búsqueda
176 Resultado(s)
- (1S, 2S, 3R, 4R)-3-(5-Fluoro-2-(3-metil-4-(4-metil-1-piperacinil)-fenilamino)-4-pirimidinilamino)-biciclo[2.2.1]5-hepteno-2-carboxamida benzoato
- (2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-((((1r,3S)-3-(2-(5-(tert-butyl)-1H-benzo[d]imidazol-2-yl)ethyl)cyclobutyl)(isopropyl) amino)methyl)tetrahydrofuran-3,4-diol
- (S)-5-(1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethylamino-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile
- (Z)-3-(3-(3,5-bis(trifluorometil)fenil-1H-1,2,4-triazol-1-il)-N'-(pirazin-2-il)acrilhidrazida
- 1,2-bis(methylsulphonyl)-1-(2-chloroethyl)-2-[(methylamino)carbonyl]hydrazine
- 1-(4-{4-amino-7-[1-(2-hidroxietil)-1H- pirazol-4-il]tieno[3,2-c]piridin-3-il}fenil)-3-(3-fluorofenil)urea
- 1-[2-(Benzo[1,2,5]thiadiazol-5-ylamin)-6-(2,6-dicloro-fenil)-pirido[2,3-d]pirimidin-7-il]-3-tert-butil-urea
- 1-ciclopropil-3-[3-(5-morfolina-4-ilmetilo-1H-benzoimidazola-2-il)-1H-pirazola-4-il]-urea
- 11-(2-pirrolidina-1-il-etoxi)-14,19-dioxa-5,7,26-triaza-tetraciclo[19.3.1.1(2,6).1(8,12)] heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-deceno
- 17-allylamino-17-demethoxygeldanamycin
- 2-((3-((4-((3-aminopropyl)amino)butyl)amino)propyl)amino)-N-((5S,5aS,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl)acetamide, tetrahydrochloride
- 2-((4S)-6-(4-chlorophenyl)-1-methyl-4H-benzo[C]isoxazolo[4,5-e]azepin-4-yl)acetamide monohydrate
- 2-[(6S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thienol[3,2,-f]-[1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl]-N-(4-hydroxyphenyl)-acetamide dihydrate
- 2-[[3-({4-[(5-{2-[(3-Fluorofenil)amino]-2-oxoetil}-1H-pirazol-3-il)amino]-quinazolin-7-il}oxi)propil](etil)amino]etil fosfato tri-hidrato di-hidrogenado
- 2-hydroxymethyl-2-methoxymethyl-1-azabicyclo[2,2,2]octan-3-one
- 2-methyl-1-[(4-[6-(trifluoromethyl)pyridin-2-yl]-6-{[2-(trifluoromethyl)pyridin-4-yl]amino}-1,3,5-triazin-2-yl)amino]propan-2-ol methanesulfonate
- 225Ac-lintuzumab
- 5'-O-(trans-9"-octadecenoyl)-1-ß-D-arabinofuranosyl cytosine
- 6-(1H-Indazol-6-yl)-N-(4-morpholinophenyl)imidazo-[1,2-alpha]pyrazin-8-amine bis-methanesulfonate
- 6-{[(1R,2S)-2-aminocyclohexyl]amino}-7-fluoro-4-(1-methyl-1H-pyrazol-4-yl)-1,2-dihydro-3H-pyrrolo[3,4-c]pyridin-3-one monocitrate
- Acetylsalicylic acid
- Alitretinoin
- Allogeneic ex vivo-generated natural killer cells from CD34+ umbilical cord blood progenitor cells
- Allogeneic multi-virus specific T lymphocytes targeting BK virus, cytomegalovirus, human herpesvirus-6, Epstein Barr virus and adenovirus
- Allogeneic, umbilical cord blood-derived, ex vivo-expanded, haematopoietic CD133+ cells / allogeneic, umbilical cord blood-derived, non-expanded, haematopoietic CD133- cells
- Alvocidib
- Amonafide L-malate
- Anagrelida
- Anticuerpo monoclonal humanizado IgG4 frente al receptor humano toll-like de tipo 2
- Antisense oligonucleotide 5'-d[P-Thio} (CCCTG CTCCC CCCTG GCTCC)-3'
- Arsenico Trioxido de
- Asciminib
- Azacitidine
- Bafetinib
- Bisantrene hydrochloride
- Bosutinib
- Clofarabine
- Clorihidrato de N-[(2S)-2,3-dihidroxipropil]-3-[(2-fluoro-4-iodofenil) amino] isonicotinamida
- Combretastatin A1 diphosphate-
- Crenolanib
- Células dendríticas humanas alogénicas derivadas de una línea de células progenitoras CD34 positivas
- Células madre de médula ósea alogénica tratadas ex vivo con 16,16-dimetil-PGE2
- Células sanguíneas alogénicas de cordón umbilical expandidas ex vivo
- Células sanguíneas alogénicas de cordón umbilical tratadas ex vivo con 16,16-dimetil-PGE2
- Dasatinib
- Daunorubicin (liposomal)
- Decitabina
- Devimistat
- Diclorhidrato de N-tert-butil-3-[(5-metil-2-{[4-(2-pirrolidin-1-iletoxi)fenil]amino}pirimidin-4-il)amino] bencenosulfonamida monohidrato
- Donor lymphocyte preparation depleted of functional alloreactive T-cells
- Fedratinib
- Fibroblast growth factor receptor (FGFR) inhibitor
- Fully human IgG1 antibody specific for CD33
- GM-CSF receptor antagonist
- Gemtuzumab Ozogamicin
- Gilteritinib
- Givinostat
- H-Tyrosine-Glycine-Phenylalanine-Glycine-Glycine-OH
- Histamine dihydrochloride
- Histona recombinante humana H1.3 y N-bis-met-Histona recombinante humana H1.3
- Homoharringtonine
- Human monoclonal antibody against inhibitory killer cell lg-like receptors (1-7 F9)
- Imatinib mesilato
- Imetelstat
- Inecalcitol
- Interferon alfa 2A
- Interferón alfa-2b pegilado sobre prolina
- Isocitrate dehydrogenase 2-mutant inhibitor
- Ivosidenib
- L-Asparaginase
- L-asparaginasa encapsulada en eritrocitos
- Laromustine
- Lenalidomida
- Lestaurtinib
- Linfocitos T alogénicos que contienen un gen exógneo que codifica TK
- Lintuzumab
- Liposomal cytarabine-daunorubicin
- Liposomal daunorubicin
- Magrolimab
- Mepolizumab
- Midostaurina
- Mitoxantrone
- Mocetinostat
- N-(2-amino-phenyl)-4-[(4-pyridin-3-yl-pyrimidin-2-ylamino)-methyl] benzamide
- N-(5-tert-butilisoxazol-3-il)-N'-{4-[7-(2-(morfolin-4-il)etoxi)imidazo[2,1-b][1,3]benzotiazol-2-il]fenil}urea, dihidrocloruro
- N-(cianometil)-4-(2-{[4-(morfolina-4-il)fenil]amino}pirimidina-4-il)benzamida sal de dihidrocloruro
- N-[(2S)-5-{[(1R, 2S)-2-(4-fluorophenyl)cyclopropyl]amino}-1-(4-methylpiperazin-1-yl)-1-oxopentan-2-yl]-4-(1H-1,2,3-triazol-1-yl)benzamide, bis-tosylate salt
- NEDD8-activating enzyme (NAE) inhibitor
- Navitoclax
- Nilotinib
- Oligonucleotido ADN fosfodiester monocatenario compuesto por 26 bases
- Oligonucleótido quimérico dirigido contra el microARN-451 que consiste de ácido nucléico bloqueado y desoxinucleósido con enlaces fosforotioato
- Omacetaxine mepesuccinate
- Onvansertib
- P-ethoxy growth factor receptor-bound protein 2 (Grb2) antisense oligonucleotide
- Plerixafor
- Plitidepsina
- Pomalidomida
- Ponatinib
- Pracinostat
- Proteína recombinante de fusión constituida por una forma modificada del dominio extracelular del receptor humano de activina tipo IIB unida al dominio Fc de la IgG1 humana
- Proteína recombinante de fusión constituída por la fracción extracelular del receptor CD95 fusionada a la fracción Fc de la immunoglobulina humana IgG1
- Recombinant human interleukin-3 truncated diphtheria toxin fusion protein
- Recombinant human pentraxin-2
- Ribonucleotide reductase R2 specific phosphorothioate oligonucleotide
- Ruxolitinib
- Sal sódica de (E)-2,4,6-Trimethoxistiril-3-carboximetilamino-4-methoxibenzilsulfona
- Sapacitabine
- Sodium (2R,3S,5R)-5-(4-amino-2-oxo-1,3,5-triazin-1(2H)-yl)-2-(hydroxymethyl)tetrahydrofuran-3-yl ((2R,3S,5R)-5-(2-amino-6-oxo-1H-purin-9(6H)-yl)-3-hydroxytetrahydrofuran-2-yl)methyl phosphate
- Sotatercept
- Stem/progenitor cells derived from ex vivo expanded allogeneic umbilical cord blood cells
- Talidomida
- Tamibaroteno
- Tipifarnib
- Tosedostat
- Trans N1-((1R,2S)-2-fenilciclopropil) ciclohexano-1, 4-diamina bis-clorhidrato
- Troxacitabina
- Ulocuplumab
- Vadastuximab talirine
- Val-Leu-Gln-Glu-Leu-Asn-Val-Thr-Val (Pr1 nanopeptide, sequence 169-177, of proteinase 3)
- Venetoclax
- Volasertib
- Vosaroxina
- Wilms' tumour 1 (WT1) vaccine
- Zosuquidar trihydrochloride
- cusatuzumab
- glasdegib
- haematopoietic stem cells and blood progenitors umbilical cord-derived expanded with (1R, 4R)-N1-(2-benzyl-7-(2-methyl-2H-tetrazol-5-yl)-9H-pyrimido[4,5-b]indol-4-yl)cyclohexane-1,4-diamine dihydrobromide dihydrate
- humanised monoclonal antibody of the IgG4 kappa isotype targeting CD47
- Ácido 4-{[(2R,3S,4R,5S)-4-(4-cloro-2-fluoro-fenil)-3-(3-cloro-2-fluoro-fenil)-4-ciano-5-(2,2-dimetill-propil)-pirrolidina-2-carbonil]-amino}-3-metoxi-benzóico
